{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "increases_activity",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "uniprot:P00439",
      "entity_text" : "PAH",
      "entity_type" : "protein"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "pubchem:11540687",
      "entity_text" : "dasatinib",
      "entity_type" : "simple_chemical"
    },
    "hypothesis_information" : false
  },
  "verbose_text" : "There are no reports of PAH following exposure to the more selective Bcr-Abl targeted TKIs (imatinib and nilotinib), which may be safely used in dasatinib induced PAH [XREF_BIBR, XREF_BIBR - XREF_BIBR].",
  "reading_complete" : "2020-07-28T10:32:26Z",
  "reader_type" : "machine",
  "reading_started" : "2020-07-28T10:28:48Z",
  "trigger" : "induced",
  "evidence" : [ "dasatinib-induced PAH" ],
  "pmc_id" : "7123056",
  "score" : 0
}